CVE-2016-8901
b2evolution 6.7.6 suffer from an Object Injection vulnerability in /htsrv/call_plugin.php.
CVE-2016-8901 is a critical vulnerability (CVSS 9.8) in B2evolution, published May 23, 2019. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 2.42%, the 84th percentile. No source names a fixed version.
b2evolution 6.7.6 suffer from an Object Injection vulnerability in /htsrv/call_plugin.php.
Attack profile
How easy it is to exploit
- Attack vector
- Network
- Complexity
- Low
- Privileges needed
- None
- User interaction
- None
What an attacker can affect
- Confidentiality
- High
- Integrity
- High
- Availability
- High
Exploit likelihood
What each source reports
NVD Score used
b2evolution 6.7.6 suffer from an Object Injection vulnerability in /htsrv/call_plugin.php.
- Record
CVE-2016-8901- CVSS 3.0
- 9.8 Critical
CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H - CVSS 2.0
- 7.5 High
AV:N/AC:L/Au:N/C:P/I:P/A:P - Weakness
- CWE-74
- Updated
- 2026-11-02
CVE List No score
b2evolution 6.7.6 suffer from an Object Injection vulnerability in /htsrv/call_plugin.php.
- Record
CVE-2016-8901- Updated
- 2026-11-02
EUVDEUVD-2016-9726 No score
b2evolution 6.7.6 suffer from an Object Injection vulnerability in /htsrv/call_plugin.php.
- Record
EUVD-2016-9726- Updated
- 2026-11-03
GitHub AdvisoriesGHSA-4r3g-2r86-vmh6
b2evolution 6.7.6 suffer from an Object Injection vulnerability in /htsrv/call_plugin.php.
b2evolution 6.7.6 suffer from an Object Injection vulnerability in /htsrv/call_plugin.php.
- Record
GHSA-4r3g-2r86-vmh6- CVSS 3.0
- 9.8 Critical
CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H - Weakness
- CWE-74
- Updated
- 2026-11-02
OSV
b2evolution 6.7.6 suffer from an Object Injection vulnerability in /htsrv/call_plugin.php.
- Record
CVE-2016-8901- CVSS 3.0
- 9.8 Critical
CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H - Updated
- 2026-11-02
Affected products
History
| When | Changed | Sources |
|---|---|---|
| 2026-11-03 | aliases | EUVD |
| 2026-11-02 | created | CVE List, GitHub Advisories, NVD, OSV |